Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2020 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications

0
251

Opportunity ID: 326712
Opportunity Number: NOT-OD-20-099
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2020 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s):
Eligible Applicants: Small businesses
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: May 01, 2020
Last Updated Date: May 01, 2020
Estimated Synopsis Post Date:
Fiscal Year: 2021
Award Ceiling:
Award Floor:
Estimated Total Program Funding:
Expected Number of Awards:
Description: This Notice is to inform the eligible United States small business concerns of the reissuance of the Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. When reissued, these FOAs will continue to utilize the R41/R42 and R43/44 grant mechanisms. Modifications to these FOAs will be the inclusion of new and revised research priorities. NIH, CDC, and FDA Institutes and Centers likely to participate in one or more of the FOAs include the following: National Institutes of Health (NIH) National Cancer Institute (NCI) National Eye Institute (NEI) National Heart, Lung, and Blood Institute (NHLBI) National Human Genome Research Institute (NHGRI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Drug Abuse (NIDA) National Institute of Environmental Health Sciences (NIEHS) National Institute of General Medical Sciences (NIGMS) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Library of Medicine (NLM) National Center for Complementary and Integrative Health (NCCIH) National Center for Advancing Translational Sciences (NCATS) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP) Centers for Disease Control (CDC) Center for Global Health (CGH/CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD/CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP/CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP/CDC) National Center for Immunization and Respiratory Diseases (NCIRD/CDC) National Center for Injury Prevention and Control (NCIPC/CDC) National Institute for Occupational Safety and Health (NIOSH/CDC) National Center for Environmental Health (NCEH/CDC) Center for Preparedness and Response (CPR/CDC) Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER/FDA) Center for Drug Evaluation and Research (CDER/FDA) Center for Food Safety and Applied Nutrition (CFSAN/FDA) Center for Devices and Radiological Health (CDRH/FDA) Center for Veterinary Medicine (CVM/FDA) Office of Critical Path Programs (CPI/FDA) Office of Orphan Products Development (OOPD/FDA) This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2020 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications

LEAVE A REPLY

Please enter your comment!
Please enter your name here